Global Bioresorbable Vascular Scaffold Market Size study & Forecast, by Application (Peripheral Artery, Coronary Artery), by End User (Hospitals, Others) and Regional Analysis, 2022-2029

Global Bioresorbable Vascular Scaffold Market Size study & Forecast, by Application (Peripheral Artery, Coronary Artery), by End User (Hospitals, Others) and Regional Analysis, 2022-2029

Global Bioresorbable Vascular Scaffold Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. The Bioresorbable Vascular Scaffold (BVS) is a non-metallic mesh tube that is generally used in the treatment of a narrowed artery. The BVC completely gets absorbed by the body leaving no foreign material. Factors such as the growing geriatric population and increasing incidences of target diseases such as rheumatic heart disease, coronary heart disease, peripheral arterial disease, cerebrovascular disease, congenital heart disease, and pulmonary embolism are driving the global market growth.

According to the World Health Organization (WHO), it was estimated that approximately 17.9 million people worldwide die every year because of cardiovascular diseases. Therefore, the high prevalence of CVDs is propelling the demand for Bioresorbable Vascular Scaffold, which, in turn, augments the market growth across the globe. In addition, rising technological advancements and a robust product pipeline are presenting lucrative opportunities for growth in the market during the forecast period. However, lack of awareness about bioresorbable vascular scaffolds and high costs related to the R&D activities are hindering market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Bioresorbable Vascular Scaffold Market study include Asia Pacific, North America, Europe, Latin America, and the Rest of the World. Europe dominated the market in terms of revenue, owing to the presence of skilled professionals and growing investment in R&D activities. Whereas the Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising expenditure on healthcare, as well as growing incidences of target diseases.

Major market players included in this report are:
Meril Life Sciences
Abbott
Cook Medical
Boston Scientific Corporation
W.L. Gore & Associates, Inc.
Medtronic
Stentys SA
MAQUET Holding B.V. & Co. KG (Getinge AB)
B. Braun Melsungen AG
Terumo Corporation
Recent Developments in the Market:
In May 2021, a study of patients with relatively simple coronary artery lesions unveils that some early promise for a new bioresorbable scaffold such as Firesorb, MicroPort Medical.
In January 2019, Reva Medical announced the expansion of the company’s commercial operations to seven additional European countries that are Estonia, Poland, Slovakia, Russia, Lithuania, the Czech Republic, and Latvia four new regional distribution partnerships.
Global Bioresorbable Vascular Scaffold Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered

Application, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define the market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study.

The report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with a detailed analysis of the competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Application:
Peripheral Artery
Coronary Artery
By End User:
Hospitals
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the WorldCompanies Mentioned

Meril Life Sciences
Abbott
Cook Medical
Boston Scientific Corporation
W.L. Gore & Associates, Inc.
Medtronic
Stentys SA
MAQUET Holding B.V. & Co. KG (Getinge AB)
B. Braun Melsungen AG
Terumo Corporation

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.